Anzai Medical Joins Forces with Leo Cancer Care as Distributor of Cutting-Edge Cancer Treatment Technology

Leo Cancer Care, a global leader in upright radiation therapy solutions, is excited to announce a new partnership with Anzai Medical Co., Ltd.

Anzai Medical, a renowned company of advanced medical technologies, will now serve as the official distributor in Japan for Leo Cancer Care’s innovative cancer treatment systems, including the Marie® upright particle therapy solution.

This collaboration marks a significant step in expanding access to the latest advancements in radiation therapy, with a shared mission to enhance patient care through efficiency, comfort, and adaptability.

Leo Cancer Care’s flagship system, Marie, introduces a revolutionary upright patient positioning system and CT scanner designed with a vision to improve patient comfort and treatment efficiency. Additionally, the Marie system is particle beam agnostic, meaning it’s compatible with various therapy modalities such as proton, carbon ion, neutron, and the emerging FLASH therapy, offering Japanese healthcare providers a future-proof solution for radiation treatment.

Anzai Medical’s extensive reach and expertise in medical technology distribution make it the ideal partner to bring Leo Cancer Care’s innovative solutions to the Japanese market. Through this partnership, cancer treatment centers across Japan will now have greater access to technology that puts patient comfort and experience at the forefront.

Stephen Towe, CEO of Leo Cancer Care, said:
“We are thrilled to partner with Anzai Medical, whose expertise and commitment to providing top-tier medical solutions align perfectly with our vision to make cancer treatment more patient-centric and accessible. Together, we aim to transform the landscape of cancer care in Japan and ensure that more patients can benefit from cutting-edge treatment technologies.”

Masaaki Yasue, President of Anzai Medical, said:
“We are honored and thrilled to partner with Leo Cancer Care, a global leader in upright radiotherapy equipment. As with our products, we look forward to bringing Leo Cancer Care’s technology to many patients and healthcare professionals in Japan.”

As a leader in advancing healthcare and embracing innovative solutions, Japan is the ideal location to pioneer the emerging practice of upright radiotherapy, setting the stage for transformative cancer treatment. 

About Leo Cancer Care
Leo Cancer Care is a global leader in the development of radiation therapy solutions designed to improve the treatment experience for both patients and clinicians. With a mission to bring a more patient-centric approach to cancer care, Leo Cancer Care focuses on upright radiation therapy systems that they hope will offer unparalleled precision and comfort. The company’s innovative technology is adaptable to various forms of particle beam therapy, making it a versatile solution for modern oncology centers.

About Anzai Medical Co., Ltd.
Founded in 1976, Anzai Medical Co., Ltd. is a leading company of advanced medical equipment in Japan. The company specializes in providing innovative healthcare solutions that improve patient care and outcomes. Over 2000 units of Anzai’s respiratory gating devices have been shipped to 35 countries around the world. In Japan, 25 out of 26 particle beam radiotherapy facilities have employed Anzai’s gating devices. With a reputation for excellence and a deep commitment to quality, Anzai Medical partners with global innovators to bring the latest medical technologies to Japanese healthcare providers.

*Please note Leo Cancer Care’s upright patient positioning system recently gained 510(k) regulatory clearance in the USA for clinical use, with a similar process underway in Europe and Asia. Marie, including the upright CT scanner, and Ruby, featuring the CBCT scanner, are not yet clinically available.